06:05:55 EDT Fri 19 Apr 2024
Enter Symbol
or Name
USA
CA



T:TH - THERATECHNOLOGIES INC. - http://www.theratech.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
TH - T  4.81.81·1.820.11.81+0.010.65.89341.80  1.84  1.805.84  1.22Apr 18Apr 1515 min RT 2¢
TSX - T4.81.81·1.820.11.81+0.010.64.88161.80  1.84  1.805.84  1.22Apr 1815 min
NEO ATS - U 1.83+0.031.70.1011.83  1.83  1.83Apr 1815 min
Omega - O 1.82+0.021.10.1011.82  1.82  1.82Apr 1815 min
Pure - P 1.800.0602    15 min
Chi-X - X 1.82+0.021.10.4111.82  1.82  1.82Apr 1815 min
CX2 - H 1.82+0.021.10.1021.82  1.82  1.82Apr 1815 min
CXD - D 1.800.0801    Apr 1615 min
TriAct - M 1.800.110    Sep 11-2015 min

Recent Trades - Last 10 of 34
Time ETExPriceChangeVolumeBuyerSellerMarkers
        
        
        
        
        
        
        
        
        
        

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2024-04-15 16:39C:TH1.80News ReleaseTheratechnologies mails proxy circular for May 9 AGM
2024-04-10 11:45C:TH2.09News ReleaseTheratechnologies loses $4.48-million (U.S.) in Q1
2024-04-10 07:54C:TH2.09SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-04-10 07:54C:TH2.09SEDAR Interim MD & ASEDAR Interim MD & A
2024-04-10 07:54C:TH2.09SEDAR Interim MD & ASEDAR Interim MD & A
2024-04-08 16:43C:TH1.93News ReleaseTheratechnologies presents preclinical data on SORT1+
2024-04-05 11:28C:TH2.06News ReleaseTheratechnologies appoints Tea as director
2024-04-03 11:00C:TH2.16News ReleaseTheratechnologies to release Q1 2024 results April 10
2024-03-22 10:56C:TH1.70News ReleaseTheratechnologies to cut preclinical cancer research
2024-03-21 20:06C:TH1.70News ReleaseTheratechnologies appoints Zwick as director
2024-03-21 10:52C:TH1.65News ReleaseTheratechnologies increases dose level in phase 1 trial
2024-02-29 16:38C:TH2.01News ReleaseTheratechnologies director Trudeau resigns
2024-02-27 08:30C:TH2.20News ReleaseTheratechnologies gets refusal-to-file letter from FDA
2024-02-21 11:32C:TH2.27News ReleaseTheratechnologies loses $23.95M (U.S.) in fiscal 2023
2024-02-21 08:41C:TH2.27SEDAR Annual ReportSEDAR Annual Report
2024-02-21 08:30C:TH2.27SEDAR MD & ASEDAR MD & A
2024-02-21 08:30C:TH2.27SEDAR MD & ASEDAR MD & A
2024-02-21 08:24C:TH2.27SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2024-02-20 12:07C:TH2.23News ReleaseTheratechnologies publishes journal article on TH1902
2024-02-15 11:25C:TH2.28News ReleaseTheratechnologies enrolls six patients in TH1902 trial